B Stankoff

Summary

Country: France

Publications

  1. ncbi request reprint Age at onset determines the occurrence of the progressive phase of multiple sclerosis
    B Stankoff
    centre d investigation clinique, AP HP, Hôpital Pitié Salpêtrière UPMC, Paris, France
    Neurology 68:779-81. 2007
  2. ncbi request reprint Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study
    B Stankoff
    Federation de Neurologie, Hopital de la Salpetriere, AP HP, Paris, France
    Neurology 64:1139-43. 2005
  3. doi request reprint Dramatic worsening following plasma exchange in severe post-natalizumab withdrawal multiple sclerosis relapse
    C Papeix
    Department of Neurology, MS Clinic, Salpetriere Hospital, Paris, France
    Mult Scler 17:1520-2. 2011
  4. ncbi request reprint Immunosuppressive therapy is more effective than interferon in neuromyelitis optica
    C Papeix
    Department of Neurology, Hopital de la Salpetriere, Paris, France
    Mult Scler 13:256-9. 2007
  5. pmc Negative regulation of central nervous system myelination by polysialylated-neural cell adhesion molecule
    P Charles
    Biologie des Interactions Neurones Glie, Institut National de la Santé et de la Recherche Médicale U 495 and Université Paris VI, Hopital de la Salpetriere, 75651 Paris Cedex 13, France
    Proc Natl Acad Sci U S A 97:7585-90. 2000

Detail Information

Publications5

  1. ncbi request reprint Age at onset determines the occurrence of the progressive phase of multiple sclerosis
    B Stankoff
    centre d investigation clinique, AP HP, Hôpital Pitié Salpêtrière UPMC, Paris, France
    Neurology 68:779-81. 2007
    ..Moreover, age at onset strongly determines the time to conversion to secondary progression for patients presenting with a relapsing form. This suggests that age at onset strongly influences the neurodegenerative component of MS...
  2. ncbi request reprint Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study
    B Stankoff
    Federation de Neurologie, Hopital de la Salpetriere, AP HP, Paris, France
    Neurology 64:1139-43. 2005
    ..To assess whether modafinil, a wakefulness-promoting agent, is useful for fatigue in patients with multiple sclerosis (MS)...
  3. doi request reprint Dramatic worsening following plasma exchange in severe post-natalizumab withdrawal multiple sclerosis relapse
    C Papeix
    Department of Neurology, MS Clinic, Salpetriere Hospital, Paris, France
    Mult Scler 17:1520-2. 2011
    ..Subsequent treatment by plasma exchanges (PLEX) was followed by a dramatic neurological worsening. This case suggests that PLEX after natalizumab discontinuation may increase relapse severity...
  4. ncbi request reprint Immunosuppressive therapy is more effective than interferon in neuromyelitis optica
    C Papeix
    Department of Neurology, Hopital de la Salpetriere, Paris, France
    Mult Scler 13:256-9. 2007
    ..The probability of relapse was significantly lower in the IS Group (P =0.0007). From our results, interferon beta is not recommended, and one of the best current therapeutic options for NMO appears to be immunosuppressants...
  5. pmc Negative regulation of central nervous system myelination by polysialylated-neural cell adhesion molecule
    P Charles
    Biologie des Interactions Neurones Glie, Institut National de la Santé et de la Recherche Médicale U 495 and Université Paris VI, Hopital de la Salpetriere, 75651 Paris Cedex 13, France
    Proc Natl Acad Sci U S A 97:7585-90. 2000
    ..Together, this suggests that myelination is tightly controlled by both positive (electrical activity) and negative (PSA-NCAM expression) regulatory signals...